Several studies question the requirement of CD21/35 high CD23 ϩ splenocytes as intermediates for follicular B cell development. Mice deficient for the transcription factor Aiolos lack MZ B cells and splenic B cells expressing high levels of IgM, CD21/35, and IgD (likely equivalent to CD21/35 high CD23 ϩ splenocytes), but have an enlarged pool of hyperactivated follicular B cells (8, 9) . Similarly, mice with a conditional deletion of the transmembrane receptor Notch2 (10), or mice that are unable to signal through the Notch pathway (11), lack MZ B cells and CD21/35 high CD23 ϩ splenocytes, whereas their follicular pool appears normal in size and function. This genetic evidence argues against classification of CD21/35 high CD23 ϩ splenocytes as intermediates in the development of follicular B cells, and instead, suggests a potential relationship with MZ B cells.
In adults, B cells are generated from B-lineage committed precursors in the BM. Newly formed sIgM ϩ B cells in the BM are subjected to multiple selective pressures that purge autoreactive B cells and guide differentiation of the remaining cells into functionally distinct peripheral B cell compartments. Ultimately, immature B cells yield follicular or marginal zone (MZ) B cells, mature subsets that differ in their surface phenotype, anatomic localization, and immunologic function (1) .
Newly formed B cells are exported to peripheral lymphoid tissues as functionally immature, or transitional, intermediates (2-7). However, the classification of immature splenic B cells and the resulting models of peripheral B cell maturation are controversial. One classification scheme put forth by Loder et al. (5) used variable surface levels of CD21/35, CD23, and IgD to divide CD24/HSA high splenic B cells into two subsets, termed T1 and T2. The T2 subset was postulated to contain precursors for follicular and MZ B cells, and seemed to be enriched for proliferative cells in vivo. An alternative classification from Allman et al. (6) used the developmental marker AA4 and variable surface levels of IgM and CD23 to delineate three transitional populations, T1 through T3. Allman et al. (6) found that the transitional subsets were nonproliferative in vivo and unresponsive to B cell receptor (BCR) cross-linking ex vivo. Thus, the T2 stage described by Loder et al. (5) may be distinct from the transitional subsets described by Allman et al. (6) . For clarity, we refer to the T2 subset described by Loder et al. as CD21/35 high CD23 ϩ splenocytes.
Several studies question the requirement of CD21/35 high CD23 ϩ splenocytes as intermediates for follicular B cell development. Mice deficient for the transcription factor Aiolos lack MZ B cells and splenic B cells expressing high levels of IgM, CD21/35, and IgD (likely equivalent to CD21/35 high CD23 ϩ splenocytes), but have an enlarged pool of hyperactivated follicular B cells (8, 9) . Similarly, mice with a conditional deletion of the transmembrane receptor Notch2 (10) , or mice that are unable to signal through the Notch pathway (11) , lack MZ B cells and CD21/35 high CD23 ϩ splenocytes, whereas their follicular pool appears normal in size and function. This genetic evidence argues against classification of CD21/35 high CD23 ϩ splenocytes as intermediates in the development of follicular B cells, and instead, suggests a potential relationship with MZ B cells.
We sought to resolve controversies regarding the classification of immature B cells and to explore lineage relationships between immature and mature B cell subsets. Accordingly, we incorporated lineage makers from diverse pheno-typing schemes, and applied kinetic studies to probe the cellular dynamics and developmental relationships among each relevant B cell subset. We find that CD21/35 high CD23 ϩ splenocytes are a nondividing cell population whose developmental kinetics and functional attributes are most consistent with a direct precursor-product relationship between CD21/35 high CD23 ϩ splenocytes and MZ B cells. We used seven-color flow cytometry to analyze simultaneously the surface markers that were used in each of these previous studies. Fig. 1 A shows sIgM and CD21/35 levels on B220 ϩ splenocytes from an 8-wk-old C57BL/6 mouse. Using initial gates similar to those of Martin and Kearney (12), we defined three fractions (Frs. I-III). These three populations were subdivided based on differential AA4 and CD23 levels, and were given the designations shown in Fig.  1 A. Most cells in Fr. I are AA4 ϩ and correspond to the bulk of immature B cells in the adult spleen. The AA4 ϩ CD23 Ϫ population in Fr. I is T1 in the nomenclature of Allman et al. (6) and Loder et al (5) , and the AA4 ϩ CD23 ϩ population is T2 in the nomenclature of Allman et al. Notably, the T2 population defined in this manner includes the CD21/35 int fraction of the T2 population as originally defined by Loder et al. (5) . The AA4 Ϫ CD23 ϩ sIgM high population of Fr. I corresponds to a recently characterized subset of recirculating cells whose development is independent of the Tec-family tyrosine kinase, Btk (13) . Fr. II includes a minor population of AA4 ϩ CD23 ϩ cells-T3 in the nomenclature of Allman et al.-whereas the bulk of Fr. II cells are AA4 Ϫ fol- (14, 15) , supports the existence of a BCR-mediated proliferative burst that is associated with the selection and expansion of useful clones among late transitional B cells. However, several studies that evaluated in vivo BrdU incorporation rates failed to observe rapid accumulation of BrdU ϩ mature B cells as predicted (3, 6, 7) . Accordingly, we directly examined cell cycle profiles for the splenic B cell subsets that are illustrated in Fig. 1 A. For these analyses, cellular doublets were excluded from postdata collection analyses (see Materials and methods). As shown in Fig. 1 C, as expected, Յ 36% and Յ 3% of BM large pre-B II cells (B220 ϩ CD25 ϩ FSC high ) and small pre-B II cells (B220 ϩ CD25 ϩ FSC low ), respectively, were contained within the G 2 /M phase of the cell cycle (16) . However, none of the splenic B cell subsets that were defined in Fig. 1 A, including the CD21/35 high CD23 ϩ subpopulation, was enriched for cells in the S or G 2 /M phases of the cell cycle ( Fig. 1 C) . We conclude that CD21/35 high CD23 ϩ splenocytes are not enriched for proliferative cells in vivo.
RESULTS

CD21
Developmental kinetics of CD21/35 high CD23 ؉ splenocytes Given the genetic data that implicate CD21/35 high CD23 ϩ splenocytes in the generation of MZ B cells (9, 10), we sought to determine developmental relationships for these populations using two complementary approaches. First, we conducted reconstitution experiments in which congenic, B220-depleted B6.Ly5 SJL BM was transferred into irradiated C57BL/6 (Ly5 B6 ) hosts, and the composition of the donorderived peripheral B cell pool was assessed each day following reconstitution, beginning on day 15. Second, we used continuous in vivo BrdU labeling to assess steady-state turnover and production rates in 8-wk-old C57BL/6 mice. Fig. 2 illustrates donor-derived B cells (B220 ϩ Ly5 SJLϩ ) in host spleens on the indicated days after reconstitution. As expected, at early time points, reconstitution was restricted to Fr. I, with the T1 and T2 AA4 ϩ populations evident at this time. In addition, the very few cells detected in Fr. II on day 15 were restricted to the AA4 ϩ T3 pool. Initial reconstitution of the follicular pool was evidenced first on day 17. By analyzing 200,000 cells per sample, we were able to detect small numbers of AA4 low CD21/35 high CD23 ϩ cells and MZ B cells at this time ( 
BrdU-labeling kinetics
To evaluate further the lineage relationships suggested by Fig. 2 , we examined the steady-state cellular dynamics of each subset illustrated in Fig. 1 by way of continuous in vivo BrdU labeling. Cohorts of 8-wk-old C57BL/6 adults were inoculated i.p. with BrdU every 12 h, and BrdU incorporation was assessed at 2, 4, or 6 days. As reported previously (6), the AA4 ϩ transitional population T2 labeled rapidly, with ‫%06ف‬ labeling by day 4. In contrast, follicular B cells, CD21/35 high CD23 ϩ splenocytes, and MZ B cells all labeled relatively slowly, with 5%, 10%, and 15% labeling on day 4, respectively ( Fig. 3 A) . We further estimated production rates for each pool. The number of CD21/35 high CD23 ϩ B cells produced per day was markedly insufficient to sustain the follicular B cell pool. Whereas 3.8 ϫ 10 5 follicular B cells were produced per day, only 0.4 ϫ 10 5 CD21/35 high CD23 ϩ B cells were generated per day (Fig. 3 B) . Significantly, CD21/35 high CD23 ϩ splenocytes exhibited slightly accelerated labeling kinetics relative to MZ B cells (Fig. 3 A) , and production rates for CD21/35 high CD23 ϩ B cells mirrored those for MZ B cells (Fig. 3 B) . These data, together with the reconstitution data in Fig. 2 , suggest a direct pre- Fig. 4 B, AA4 ϩ T2 splenocytes efficiently gave rise to MZ B cells in RAG2 Ϫ/Ϫ hosts at day 4, but gave rise to CD21/35 int IgM int/lo CD23 ϩ CD1d low follicular B cells in C57BL/6 hosts. Importantly, at day 2.5 after transfer, the AA4 ϩ T2 splenocytes in RAG2 Ϫ/Ϫ hosts expressed high levels of CD21/35 and sIgM, and maintained high expression of CD23 and sIgD (Fig. 2 B, first row) . Thus, AA4 ϩ T2 splenocytes transit through a CD21/35 high CD23 ϩ stage en route to the MZ B stage.
Because the host environment influenced whether recovered AA4 ϩ T2 cells exhibited a follicular or MZ B cell surface phenotype (Fig. 4 B) , we further reasoned that mature follicular B cells also might yield MZ B cells when transferred into B cell-deficient, but not B cell-sufficient, hosts. Previous studies that employed transfer of unfractionated B cells from the mouse lymph node or rat thoracic duct suggested that mature B cells generate MZ-like B cells upon transfer into lymphopenic hosts (19, 20) . However, these MZ-like cells also may derive from late transitional B cells, which are readily detectable in the lymph node and among recirculating B cells in the peripheral blood (unpublished data). Accordingly, we determined whether highly purified splenic follicular B cells, as defined in Fig. 1 , yielded MZ B cells when transferred into RAG2 Ϫ/Ϫ hosts, and whether such differentiation was accompanied by the initial acquisition of a sIgM high CD21/35 high CD23 ϩ surface phenotype. As shown in Fig. 4 C, at day 2.5 after transfer, donor B cells that were recovered from RAG2 Ϫ/Ϫ hosts were CD21/35 high CD23 ϩ sIgM high . By day 4.5, a subset of the donor B cells had down-regulated CD23, and by day 8.5, donor B cells also were sIgD low , which indicated further differentiation along the MZ B cell pathway (Fig. 4 C) . In contrast, at day 2.5 and all subsequent time points, donor B cells that were recovered from C57BL/6 hosts retained a sIgM low CD21/35 low CD23 ϩ surface phenotype that is typical of follicular B cells. We also conducted immunohistochemical and functional analyses to test whether (21), and acquired the capacity to trap T-independent antigens (22, 23) and stimulate allogeneic CD4 ϩ T cells in a mixed lymphocyte reaction (24) . Again, cell recoveries for all follicular B cell transfers typically were 1-2% of the donor inoculum, but sort purities for follicular B cells typically were ‫,%99ف‬ with Ͻ0.1% contamination by MZ B cells (unpublished data). These high sort purities, the stepwise differentiation of AA4 ϩ T2 and follicular B cells in RAG2 Ϫ/Ϫ hosts, and the maintenance of the follicular phenotype in C57BL/6 hosts argue that selective survival of contaminating MZ B cells is unlikely to account for these data. Overall, these results strengthen the notion that CD21/35 high CD23 ϩ splenocytes are an intermediate in the differentiation pathway of MZ B cells. (25) . Thus, CD21/35 high CD23 ϩ splenocytes may exhibit enhanced binding to intercellular adhesion molecule, but not to VCAM. We also assayed the expression of markers that were reported to differ on MZ B cells and follicular B cells. The glycolipid presentation molecule, CD1d, is expressed at higher level on MZ B cells (26) and, in line with previous findings (27) , has intermediate expression on CD21/ 35 high CD23 ϩ splenocytes relative to AA4 ϩ T2 and follicular B cells. In addition, the adhesion molecule CD9 is expressed preferentially on MZ B cells (28) and shows intermediate levels on CD21/35 high CD23 ϩ splenocytes. Finally, expression of the Toll-like receptor homologue RP105 was expressed at roughly equivalent levels on MZ and CD21/35 high CD23 ϩ splenocytes, and was significantly higher on these cells compared with follicular and AA4 ϩ T2 B cells.
Finally, we assessed whether CD21/35 high CD23 ϩ splenocytes exhibit robust proliferation to LPS, which is characteristic of MZ B cells (29) . Fig. 6 A shows the proliferation profiles of sorted, carboxyl fluorescein succinimidyl ester (CFSE)-labeled follicular, CD21/35 high CD23 ϩ and MZ B cells that were stimulated by BCR cross-linking or LPS. Fig.  6 B shows the responder frequencies and proliferative capacities that were calculated from these CFSE profiles (30) . Like MZ B cells, CD21/35 high CD23 ϩ splenocytes show a much stronger response to LPS than do follicular B cells. This greater response is reflected in a larger responder frequency, rather than a greater proliferative capacity. Strikingly, CD21/ 35 high CD23 ϩ splenocytes also responded robustly to BCR cross-linking, which distinguishes them from MZ B cells and from AA4 ϩ transitional cells, which are nonproliferative to BCR cross-linking (6, 29) . Thus, CD21/35 high CD23 ϩ splenocytes share many characteristics with MZ B cells, but are not functionally equivalent to MZ B cells. Overall, these 
DISCUSSION
Nonfollicular CD23 ϩ splenic B cells can be divided into at least two subsets (Fig. 1 A) : a CD21/35 int subset that expresses relatively high levels of AA4, and a CD21/35 high subset that expresses low to background levels of AA4. The former AA4 ϩ CD21/35 int subset corresponds to the T2 population of Allman et al. (6) and includes a fraction of the T2 population of Loder et al. (5), whereas the latter AA4 low CD21/35 high subset corresponds to a fraction of the T2 population that was defined by Loder et al. (5) . This population, which we have referred to as CD21/35 high CD23 ϩ splenocytes, has many characteristics that distinguish it from the bulk of immature cells and strongly implicate it as a precursor pool for MZ B cells. During the early establishment of the B cell pool, development of this subset is delayed compared with the AA4 ϩ pools, T1 and T2; it coincides with the development of follicular B cells; and it immediately precedes initial reconstitution of the MZ B cell pool (Fig. 2) . Moreover, BrdU labeling in adults indicates that the CD21/ 35 high CD23 ϩ splenocytes turn over relatively slowly, and are generated in small numbers that are sufficient to account for MZ B cell, but not for follicular B cell, production (Fig. 3) . Adoptive transfer experiments indicate that CD21/35 high CD23 ϩ splenocytes are an intermediate in the development of MZ B cells from AA4 ϩ T2 splenocytes or follicular B cells (Fig. 4) in RAG2 Ϫ/Ϫ hosts. Taken together, ontogenic relationships, population dynamics, and lineage potentials that were revealed by adoptive transfer argue against the classification of CD21/35 high CD23 ϩ splenocytes as significant intermediates in the development of follicular B cells, and support a precursor-product relationship with MZ B cells.
Several groups have investigated the characteristics of CD21/35 high CD23 ϩ splenocytes and have interpreted their findings in the context of follicular B cell development. However, our data suggest that many of the characteristics that are attributed to late transitional B cells in these studies may reflect events that are associated with MZ, rather than follicular B cell, development. For instance, the reported upregulation of survival molecules among CD21/35 high CD23 ϩ splenocytes in response to BCR signaling that was observed by Su and Rawlings (14) and Petro et al. (15) , may reflect BCR-mediated selection events that are associated with prolonged survival of MZ B cells, which unlike follicular B cells, persist after cessation of B cell production in the BM (31) . Likewise, the exquisite sensitivity of CD21/35 high CD23 ϩ splenocytes to levels of the prosurvival cytokine, BLyS (32, 33) , most likely reflects a more stringent requirement for BLyS in the development and maintenance of MZ cells and their precursors as compared with follicular B cells. Similarly, many discrepancies in the literature can be clarified by interpreting the CD21/35 high CD23 ϩ splenocyte as a MZ B cell precursor. In certain lymphopenic mice, such as IL-7R␣ Ϫ/Ϫ and xid mice, MZ B cells and CD21/35 high CD23 ϩ splenocytes are maintained, whereas AA4 ϩ transitional and (Fig. 4 A) , which binds to VCAM and is required to maintain MZ B cells in their anatomic niche (25) . This difference in integrin expression may contribute to the localization of CD21/35 high CD23 ϩ splenocytes to the follicle, rather than the MZ (5, 37). Second, CD21/35 high CD23 ϩ splenocytes respond robustly to stimulation by BCR cross-linking and LPS treatment, whereas MZ B cells are unresponsive to stimulation through the BCR but are robustly responsive to LPS (15, 38) . The enhanced frequencies of LPS-responsive cells in the MZ and CD21/35 high CD23 ϩ pools correlated with increased surface levels of the toll-like receptor homologue, RP105, a component of the RP105/MD-1 complex that is associated with LPS responsiveness (39) . Thus, it is tempting to speculate that LPS responsiveness for all splenic B cells-regardless of their subset designation-may relate directly to surface densities of RP105 on individual cells within each population. Third, unlike MZ B cells, the development of CD21/35 high CD23 ϩ splenocytes seems to be independent of CD19, because CD19 cre/cre mice lack MZ B cells (40) , but contain normal frequencies of CD21/35 high CD23 ϩ splenocytes (unpublished data). The characteristics of MZ B cells and CD21/35 high CD23 ϩ splenocytes indicate functional distinctions between these cells, and support a paradigm where developmental cues that act on the CD23 ϩ CD21/35 high population initiate or complete full differentiation of MZ B cells.
It is possible that a small fraction of follicular B cells derive from CD21/35 high CD23 ϩ splenocytes during steadystate B cell development. When transferred into lymphosufficient hosts, CD21/35 high CD23 ϩ splenocytes give rise to cells with a follicular surface phenotype, although their sIgM and CD21/35 levels are, on average, greater than those of follicular B cells (Fig. 4 A) . Whereas this result suggests a degree of plasticity among CD21/35 high CD23 ϩ splenocytes, it is difficult to ascertain clear precursor-product relationships from these experiments, which typically are characterized by poor donor cell survival that likely is due to the failure of donor cells to compete effectively with host cells for critical microenvironmental niches. Neither the AA4 ϩ T2 (Fig. 4 B) nor T1 subsets (not depicted) yielded MZ B cells upon adoptive transfer into lympho-sufficient hosts, which suggested that all donor cells failed to gain access to limiting factors that are required uniquely for MZ B cell differentiation. Although the nature of these factors is not entirely clear, they likely include the Notch2 ligand Delta-Like-1 (41) , and the antiapoptotic cytokine BLyS (32, 33) . Likewise, because each population tested gave rise to MZ-like B cells when transferred into RAG2 Ϫ/Ϫ hosts, we further suggest that resources that are required for MZ B cell generation are available more readily in lymphopenic environments, which can promote development of MZ B cells from multiple precursor populations (Fig. 4) .
Given our data, together with genetic data from the Aiolos-and Notch-deficient mice (9-11), we propose that CD21/35 high CD23 ϩ splenocytes be termed marginal zone B cell precursors. A similar suggestion was made recently by Pillai et al. (42) . We further propose a model of peripheral B cell development, in which AA4 ϩ T2 splenocytes are the common precursor of follicular and MZ B cells and CD21/35 high CD23 ϩ splenocytes are the immediate precursor of MZ B cells (Fig. 7) . In addition to clarifying developmental relationships among splenic B cells, clear resolution of MZ B cell precursors will allow better characterization of the requirements for MZ versus follicular B cell development. Studies which compare the gene expression profiles of AA4 ϩ transitional populations, versus CD21/35 high CD23 ϩ and MZ B cells, should be especially useful in defining the molecular requirements that signal MZ B cell development.
MATERIALS AND METHODS
Mice. 6-10-wk-old C57BL/6 (Ly5 B6 ), congenic B6.Ly5 SJL (often termed B6.Ly5.2), and RAG2 Ϫ/Ϫ mice were obtained from Jackson ImmunoResearch Laboratories or the National Cancer Institute. All live animal experiments were performed according to protocols that were approved by the Office of Regulatory Affairs of the University of Pennsylvania in accordance with guidelines set forth by the National Institutes of Health. The first cells to colonize the spleen are the AA4 ϩ T1 subset, which yields the AA4 ϩ T2 subset that represents the common precursor of follicular and MZ B cells. CD21 high CD23 ϩ splenocytes are the immediate precursor of MZ B cells, and might arise from AA4 ϩ T2 cells, follicular B cells, or both. It also is possible that CD21 high CD23 ϩ splenocytes make a small contribution to the follicular pool, or that this subset is in dynamic equilibrium with the follicular subset. The relative thickness of the arrow represents the estimated flux from one compartment to another based on BrdU-labeling kinetics.
